Esophageal actinomycosis in a patient with AIDS. by Lee, S. A. et al.
YALE JOURNAL OF BIOLOGY AND MEDICINE 74 (2001), pp. 383-389.
Copyright X 2002. All rights reserved.
CASE REPORT
Esophageal Actinomycosis in a
Patient with AIDS
Samuel A. Leea,bc, G. William Palmerb, and Elizabeth L. Cooneya,b
alnfectious Disease Section, bDepartment ofMedicine, Yale University School of
Medicine, New Haven, Connecticut
Actinomycosis has been rarely reported in patients with HIV/AIDS in contrast to other opportunis-
tic and common pathogens. We report a case ofesophageal ulcer disease, secondary to actinomy-
cosis occurring in a patient with recurrent odynophagia. The diagnosis was made histologically
only after repeated upper endoscopy with biopsies.
INTRODUCTION
HIV-infected persons are at increased
risk of developing a wide array of infec-
tions due to opportunistic and routine
pathogens. Despite this, actinomycosis has
been rarely described in this population.
We report a case of esophageal actinomy-
cosis occurring in an HIV-infected patient,
whose clinical course was complicated by
recurrent esophageal ulcers.
CASE REPORT
A 41-year-old African-American male
with late stage HIV infection (absolute
CD4+ lymphocyte count 14 cells/mm3 and
plasma HIV RNA 95,000 copies/ml) pre-
sented in October 1997 for evaluation of
severe odynophagia. Physical examination
was unremarkable except for poor denti-
tion. There was no history ofheavy alcohol
use. He was empirically treated with flu-
conazole (100 mg per day) for one week
without resolution ofsymptoms. An esoph-
agogastroduodenoscopy (EGD)d was then
performed, which showed a 5-cm distal
esophageal ulcer. Histology of esophageal
biopsies revealed no evidence ofmalignan-
cy or viral inclusions, and special stains
were negative for cytomegalovirus (CMV),
herpes simplex virus (HSV), and fungi.
Viral cultures were also negative.
Omeprazole was prescribed to help pro-
mote healing of the ulcer. The patient clin-
ically improved, suggesting an initial non-
infectious etiology ofthe ulcer. He was dis-
charged with follow-up scheduled to
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reassess symptoms anddiscuss initiation of
antiretroviral therapy.
The patient was lost to follow-up until
two months later, when he presented with
recurrent odynophagia and decreased oral
intake. Oral examination showed moderate
thrush. The patient was treated with flu-
conazole (100 mg per day) for seven days
without improvement, at which time a sec-
ond EGD was performed, which showed
the previously visualized distal esophageal
ulcer, although now overlain with yellow
exudate. Esophageal brushings were posi-
tive for budding yeast, consistent with
Candida species. Mycology culture was
not performed. Viral cultures were again
negative. The patient was continued on
fluconazole; he clinically improved and
was discharged to complete a two-week
course of therapy as an outpatient with
close clinical follow-up planned.
The patient was again lost to follow-
up and presented two months later com-
plaining of progressively worsening
odynophagia. Oral examination was nega-
tive. A third EGD was performed, which
now showed two deep hemi-circumferen-
tial ulcers, one corresponding to the previ-
ously visualized lesion, and a new, more
distal ulcer measuring 3-cm. Histology of
biopsy specimens revealed rare budding
yeast and numerous sulfur granules con-
taining abundant fine elongate hyphal
forms consistent withActinomyces species
(Figure 1). Fungal culture grew 3+
Candida glabrata. Bacterial cultures were
not performed. Viral studies were again
negative.
The patient was treated with intra-
venous penicillin G (20 million units per
day in divided doses) and amphotericin B
suspension. Within four days, he showed
marked clinical improvement. He was dis-
charged to home where he completed six
weeks ofintravenous penicillin therapy, at
which time his symptoms had fully
resolved. A six-month course ofpenicillin
VK (500 mg QID) was prescribed and dis-
cussions regarding antiretroviral therapy
were planned. Unfortunately, the patient
was again lost to follow-up.
DISCUSSION
Actinomyces comprise part ofthe nor-
mal oral flora, and may colonize the gas-
trointestinal tract, bronchial tree, and
female genital tract. As human commen-
sals, these organisms have a low degree of
pathogenicity and generally only cause
infection following disruption of normal
barriers, such as after local trauma [1].
Infection often occurs in association with
other pathogenic organisms [2]. All age
groups can be affected, although actino-
mycosis is seen less frequently in persons
less than 10 or greater than 60 years of
age. There appears to be a male predomi-
nance [3, 4]. Most affected individuals
have underlying co-morbid conditions,
such as odontogenic disease, recent
surgery, cardiovascular disease, or malig-
nancy [2]. Actinomycosis is not usually
considered an HIV-related opportunistic
infection, and it appears to be a rare event
in HIV-infected persons. This may be in
part due to the frequent use of antibiotics
in this population, many of which have
activity against Actinomyces. However, it
remains unclear which components of the
immune response are most important in
controlling actinomycosis and the specific
impact of HIV/AIDS in these infections.
Actinomyces species most commonly
cause disease of the oral-cervicofacial
regions, less commonly the thorax,
abdomen, or pelvis and rarely the central
nervous system. Infection of nearly every
anatomic site in the alimentary tract, from
the oropharynx to rectum, has been report-
ed. However, there are only four cases in
the literature ofesophageal actinomycosis,
three occurring in HIV-infected individu-
als, and the fourth in a patient with pan-
creatic adenocarcinoma [5].Lee et al.: Esophageal Actinomycosis 385
Figure 1. Esophageal biopsy showing squamous mucosa with ulcer and numerous
sulfur granules containing abundant fine elongate hyphal forms consistent with
Actinomyces. Immunostains were negative for CMV and HSV.
In the two cases ofesophageal actino-
mycosis described by Poles et al. [6], both
patients had advanced HIV infection and
CMV esophagitis. Following initial
improvement from systemically adminis-
tered antivirals, each patient presented
with fever and recurrent odynophagia, at
which time repeat upper endoscopy was
performed, which revealed Actinomyces
by histologic analysis. The patients evi-
denced symptomatic as well as endoscop-
ic resolution of their infections following
prolonged treatment with IV and/or oral
penicillin (Table 1). Spencer et al. [7]
reported the third case ofesophageal actin-
omycosis. The patient was a 47-year-old
HIV-infected male, who presented with
odynophagia, accompanied by thrush on
oral examination. Endoscopy showed
white esophageal plaques, and histology
revealed sulfur granules and Gram-posi-
tive branching bacteria consistent with
actinomycosis. Unfortunately, treatment
data were not provided. In this report, the
patient had concurrent candidal infection
andpossibly also aphthous ulcerdisease of
the esophagus. It is presumed that the
mucosal disruption of the esophagus
caused by these events allowed
Actinomyces to establish infection at this
site.
There are 13 additional cases ofactin-
omycosis occurring in HIV-infected per-
sons reported in the literature (Table 1). Of
these, 10 cases were male, one female, and
two were not specified. The mean age was
35 years (range, 23 to 51 years). As
occurred with our patient, the majority of
cases were diagnosed by histology
(seven), as opposed to culture (six), thelat-
ter not performed due to either lack of
clinical suspicion and/or the known fastid-
ious nature ofthe organism. Sites ofinfec-
tion were cervicofacial (seven), thoracic
(three), gastrointestinal (two) and cuta-
neous (one). This distribution by anatomic
site ofdisease is similar to that reported in
non-AIDS case series. CD4+ lymphocyte
counts were noted in only five cases, and
ranged from 2 cells/mm3 to 499
cells/mm3. Thus, actinomycosis may
occur in patients with relatively early asLee et al.: EsophagealActinomycosis
Table 1. Cases of actinomycosis and HIV Infection in the literature.
Age/ Additional
Case Sex Conditions Location Diagnosis Treatment Outcome Comments
Yeager 23/M
1986
Gresser 29/F
1988
Klapholz 42/M
1989
Cervico- Cx, IV PCN x Recovered Had marked
facial, A. israeli 6 wk but had R sided
S/p dental PO PCN x 3 persistent adenopathy
extraction mo adenopathy the neck and
axilla, with
involvement
of R mandible
Cutaneous Cx, Cefotaxime, Recovered Disseminated
lower A. israeli metronida- skin abscesses
extremity zole, (German)
ofloxacin,
debridement
IVDU Pulmonary Histology IV PCN Recovered Othercultures
alcoholism, (trans- negative
poor dentition bronchial bx)
Fry 42/M H/o UGI Perianal Cx, Incision & Recovered Enterococcus
1991 bleed due to fistula A. naelundii drainage, PO and E. coli
gastric ulcer, PCN x 6 wk also isolated
h/o perirectal
abscess
Watkins 29/M IVDU, h/o Oral
1991 pneumocystis
pneumonia,
poor dentition
Molina 28/M
1991
Cx, Debridement Recovered Nonhealing
A. naelundii IV PCN dental
extraction site
IVDU Cervical Histology Debridement Recovered (Spanish)
(surgical PCN
specimens)
Anorectal Cx,
with sinus A. israeli
Spencer 47/M Oral thrush, Esophageal Histology
1993 oral hairy (EGD)
leukoplakia
PCN Recovered Presented
with diarrhea;
initial
diagnosis was
Crohn's disease
NS NS No details of
treatment or
outcome
provided
Endo- Histology IV PCN Died from Sputum Cx
bronchial (bronchial cryptococcal grew H.
lesion washings) meningitis influenzae, Bx
showed only
necrotic
material
Smith 28/M
1992
Cendan 47/M
1993
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Table 1. Cases of actinomycosis and HIV Infection in the literature (continued).
Age/ Additional
Case Sex Conditions Location Diagnosis Treatment Outcome Comments
Poles 42/M
1994
H/o CMV Esophageal Histology IV PCN x 6 wk, Recovered F/u EGD
gastritis, h/o (EGD) PO PCN x 1 yr showed
micro- complete
spordial resolution
eneritis, S.
aureus
bacteremia,
CMV
esophagitis
29/M CMV
esophagitis,
MAI
duodenitis
Kingdom 51/M
1994
Esophageal Histology PO PCN x 6 mo Recovered F/u EGD and
(EGD) Bx showed
complete
resolution
H/o IVDU, Nasal septum Histology PO PCN Recovered
h/o (Bx) Debridement
pulmonary
tuberculosis,
h/o old facial
trauma, CD4
count = 499
Manfredi 25/NS
1995
CD4 count = 9 Oro-
pharyngeal
Histology Fluconazole Died from Had
(Bx) ceftriaxone, interstitial progressive
netilmycin; pneumonia disease
followed by leading to
itraconazole, extensive
ceftazidime bony
destruction
and large
orononasal
fistula
36/NS CD4 count = 2 Oro-
pharyngeal
Vazquez 31/M
1997
Histology Multiple Died from Had
(Bx) antibiotics disseminated progressive
including IV M. Kansaii disease
PCN infection and leading to
toxoplasmic extensive
encephalitis bony
destruction
and large
orononasal
fistula
IVDU, Tongue Cx PO
hepatitis B, (submucosal (aspiration) amoxicillin,
CD4 nodule) [species not wide
count = 480 specified] debridement
Recovered
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Table 1. Cases of actinomycosis and HIV Infection in the literature (continued).
Age/ Additional
Case Sex Conditions Location Diagnosis Treatment Outcome Comments
Ossorio 41/M Alcoholism, Pulmonary Histology IV PCN x 3 wk, Recovered Had bilateral
1997 poor (BAL and PO ampicillin nodular
dentition, brushings) x 6 mo infiltrates on
CD4 chest CT
count = 340
Present 41/M Candida and Esophageal Histology IV PCN x 6 wk, Recovered
1998 CMV (EGD) PO PCN x 6 wk
esophagitis,
aphthous
ulcers
Cx, culture; Bx, biopsy; NS = not specified
well as advanced HIV disease. However,
four of the cases had one or more AIDS-
defining diagnoses at the time of diagno-
sis. Other co-morbid conditions included
intravenous drug use (five), poor dentition
(three), and alcoholism (two). The majori-
ty of patients (11) were treated with pro-
longed courses of penicillin or amoxi-
cillin. Surgical intervention, usually
debridement, was also performed in six of
the 13 cases. Overall, 10 patients recov-
ered or significantly improved and three
patients died (two of progressive destruc-
tive facial actinomycosis, the third ofcryp-
tococcal meningitis).
The treatment ofchoice for actinomy-
cosis remains penicillin, typically admin-
istered initially via intravenous route for
two to six weeks, employing a dose in the
range of 18 to 24 millionunits perday, fol-
lowed by oral therapy with either peni-
cillin VK or amoxicillin for six to 12
months. Less extensive infection occurring
in an immunocompetent patient, particu-
larly when limited to the cervicofacial
region, may not require such a prolonged
course of treatment. Minocycline, tetracy-
cline, erythromycin, and clindamycin may
be considered as alternatives. Anecdotal
success has also been reported with ceftri-
axone [8] and imipenem [9].
In summary, although seemingly rare,
Actinomyces can occasionally cause inva-
sive disease in persons with HIV infec-
tion. The rarity ofthis event is noteworthy,
given the multiple defects in host immune
function which occur during the HIV dis-
ease course. It remains unclear, how
HIV/AIDS affects the frequency and pro-
gression of actinomycosis in this popula-
tion. As Actinomyces can infect virtually
any anatomic site, ahigh degree ofclinical
suspicion is required to make the diagno-
sis, particularly in patients who develop
recurrent symptoms despite appropriate
therapy for a previously identified alter-
nate infection. Prior mucosal injury,
resulting from another infectious or
inflammatory process, with resultant loss
of normal protective anatomical barriers,
may be a necessary antecedent event for
invasive disease to occur. With prolonged
antibiotic therapy, and in select cases sur-
gical debridement, Actinomyces infection
can often be successfully managed.
Whether or not addition of highly active
antiretroviral therapy would allow a short-
er course ofantibiotic therapy than is gen-
erally recommended, and/or prevents the
need for surgical intervention, is unclear
from the available published literature.Lee et al.: Esophageal Actinomycosis 389
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